A S Lee1,2,3, S Colagiuri3,4, J R Flack1,5,6. 1. Department of Diabetes and Endocrinology, Bankstown-Lidcombe Hospital, Sydney, NSW, Australia. 2. Department of Endocrinology, Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia. 3. Sydney Medical School, Charles Perkins Centre, Sydney, NSW, Australia. 4. Boden Institute of Obesity, Nutrition, Exercise& Eating Disorders, University of Sydney, Sydney, NSW, Australia. 5. University of New South Wales, Sydney, NSW, Australia. 6. Western Sydney University, Sydney, NSW, Australia.
Abstract
AIM: We developed and implemented a national audit and benchmarking programme to describe the clinical status of people with diabetes attending specialist diabetes services in Australia. METHODS: The Australian National Diabetes Information Audit and Benchmarking (ANDIAB) initiative was established as a quality audit activity. De-identified data on demographic, clinical, biochemical and outcome items were collected from specialist diabetes services across Australia to provide cross-sectional data on people with diabetes attending specialist centres at least biennially during the years 1998 to 2011. RESULTS: In total, 38 155 sets of data were collected over the eight ANDIAB audits. Each ANDIAB audit achieved its primary objective to collect, collate, analyse, audit and report clinical diabetes data in Australia. Each audit resulted in the production of a pooled data report, as well as individual site reports allowing comparison and benchmarking against other participating sites. CONCLUSIONS: The ANDIAB initiative resulted in the largest cross-sectional national de-identified dataset describing the clinical status of people with diabetes attending specialist diabetes services in Australia. ANDIAB showed that people treated by specialist services had a high burden of diabetes complications. This quality audit activity provided a framework to guide planning of healthcare services.
AIM: We developed and implemented a national audit and benchmarking programme to describe the clinical status of people with diabetes attending specialist diabetes services in Australia. METHODS: The Australian National Diabetes Information Audit and Benchmarking (ANDIAB) initiative was established as a quality audit activity. De-identified data on demographic, clinical, biochemical and outcome items were collected from specialist diabetes services across Australia to provide cross-sectional data on people with diabetes attending specialist centres at least biennially during the years 1998 to 2011. RESULTS: In total, 38 155 sets of data were collected over the eight ANDIAB audits. Each ANDIAB audit achieved its primary objective to collect, collate, analyse, audit and report clinical diabetes data in Australia. Each audit resulted in the production of a pooled data report, as well as individual site reports allowing comparison and benchmarking against other participating sites. CONCLUSIONS: The ANDIAB initiative resulted in the largest cross-sectional national de-identified dataset describing the clinical status of people with diabetes attending specialist diabetes services in Australia. ANDIAB showed that people treated by specialist services had a high burden of diabetes complications. This quality audit activity provided a framework to guide planning of healthcare services.
Authors: Angela S Lee; Nathan A Johnson; Margaret J McGill; Jane Overland; Connie Luo; Callum J Baker; Sergio Martinez-Huenchullan; Jencia Wong; Jeffrey R Flack; Stephen M Twigg Journal: Diabetes Care Date: 2020-07-09 Impact factor: 19.112
Authors: Jincy Immanuel; Jeff Flack; Vincent W Wong; Lili Yuen; Carl Eagleton; Dorothy Graham; Janet Lagstrom; Louise Wolmarans; Michele Martin; Ngai Wah Cheung; Suja Padmanabhan; Victoria Rudland; Glynis Ross; Robert G Moses; Louise Maple-Brown; Ian Fulcher; Julie Chemmanam; Christopher J Nolan; Jeremy J N Oats; Arianne Sweeting; David Simmons Journal: Int J Environ Res Public Health Date: 2021-05-04 Impact factor: 3.390
Authors: Sara Guillen-Aguinaga; Luis Forga; Antonio Brugos-Larumbe; Francisco Guillen-Grima; Laura Guillen-Aguinaga; Ines Aguinaga-Ontoso Journal: J Clin Med Date: 2021-12-14 Impact factor: 4.241